Cannabis Stock Gainers And Losers From January 7, 2022
GAINERS:
Cannabix Technologies (OTC:BLOZF) shares closed up 10.07% at $0.45
Encompass Health Announces Plans To Build An Inpatient Rehabilitation Hospital In Amarillo, Texas
Encompass Health Corp. (NYSE:EHC) today announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Amarillo, Texas.
The hospital will be located north of the Wallace Boulevard and Gentry
Raymond James Maintains Strong Buy on Encompass Health, Lowers Price Target to $90
Raymond James analyst John Ransom maintains Encompass Health (NYSE:EHC) with a Strong Buy and lowers the price target from $107 to $90.
Recap: Encompass Health Q3 Earnings
Encompass Health (NYSE:EHC) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For October 27, 2021
Companies Reporting Before The Bell
• McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion.
Earnings Outlook For Encompass Health
Encompass Health (NYSE:EHC) is set to give its latest quarterly earnings report on Wednesday, 2021-10-27. Here's what investors need to know before the announcement.
Analysts estimate that Encompass Health will likely report an Earnings Per Share (EPS) of $1.06
Encompass Health Reports Expansion Of Home Health Joint Venture In Miami With Baptist Health South FLorida
Encompass Health Corp. (NYSE:EHC), a national leader in integrated post-acute healthcare services, and Baptist Health South Florida are pleased to announce the expansion of a joint venture agreement to include the
Analyst Ratings For Encompass Health
Over the past 3 months, 5 analysts have published their opinion on Encompass Health (NYSE:EHC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Truist Securities Maintains Buy on Encompass Health, Lowers Price Target to $88
Truist Securities analyst David Macdonald maintains Encompass Health (NYSE:EHC) with a Buy and lowers the price target from $100 to $88.